Investigation of the Clinical Effect of Large Volume Leukocytapheresis on Methotrexate-Resistant Rheumatoid Arthritis

: Leukocytapheresis (LCAP) is already being used in a clinical setting for the treatment of autoimmune diseases such as inflammatory bowel disease and rheumatoid arthritis, and it has been reported to be effective. However, it is totally or partially ineffective in some patients, which has forced c...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Therapeutic apheresis and dialysis 2006-10, Vol.10 (5), p.404-411
Hauptverfasser:	Onuma, Shin, Yamaji, Ken, Kempe, Kazuo, Ogasawara, Michihiro, Ogawa, Takasuke, Yang, Kwangseok, Kanai, Miki, Tsuda, Hiroshi, Takasaki, Yoshinari
Format:	Artikel
Sprache:	eng
Schlagworte:	ACR core set Aged Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - blood Arthritis, Rheumatoid - therapy C-Reactive Protein - analysis Female Humans Interleukin-6 - blood Leukapheresis - methods Leukocytapheresis Male Matrix Metalloproteinase 3 - blood Methotrexate Methotrexate - therapeutic use Middle Aged Retreatment Rheumatoid arthritis Treatment Failure
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!